Drugs / MG-1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02019056 | Nov 2010 → Dec 2014 | alcoholic fatty liver disease, alcoholic hepatitis | PharmaKing | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MG-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02019056 ↗ |